The Slow Pandemic: Emergence of Antimicrobial Resistance in the Postadvent of SARS‐CoV‐2 Pandemic DOI Creative Commons
Ayodeji Charles Osunla, Femi F. Oloye,

Adeoye John Kayode

et al.

Global Health, Journal Year: 2025, Volume and Issue: 2025(1)

Published: Jan. 1, 2025

Background: The unprecedented outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic has dramatically changed global approach to public health, emphasizing importance measures control and prevent infections. In response COVID‐19 crisis, stringent hygiene practices surface disinfection have become norm, with an surge in use disinfectants antiseptics (DAs). Main Text: While these been crucial curbing spread virus, emerging concern taken center stage: potential impact prolonged widespread antimicrobial compounds products on development antibiotic resistance. Antimicrobial resistance (AMR) long recognized as one most pressing health threats. Quaternary ammonium (QAC) such benzalkonium chloride, benzethonium cetylpyridinium which are extensively used DAs formulations, gained less attention context AMR. Conclusion: A high abundance QACs was detected wastewater, certain bacteria Pseudomonas aeruginosa, Acinetobacter baumannii , Enterococcus species developed over time. We analyzed available evidence from scientific literature, examining presence concentrations different water sources, their mechanisms. This review aimed shed light multifaceted challenges that arise dual battle against ongoing fight

Language: Английский

Current trends in the epidemiology of multidrug-resistant and beta-lactamase-producing Pseudomonas aeruginosa in Asia and Africa: a systematic review and meta-analysis DOI Creative Commons
Mohd Zulkifli Salleh, Nik Mohd Noor Nik Zuraina, Zakuan Zainy Deris

et al.

PeerJ, Journal Year: 2025, Volume and Issue: 13, P. e18986 - e18986

Published: Feb. 24, 2025

Pseudomonas aeruginosa continues to be a significant contributor high morbidity and mortality rates worldwide, particularly due its role in severe infections such as hospital-acquired conditions, including ventilator-associated pneumonia various sepsis syndromes. The global increase antimicrobial-resistant (AMR) P. strains has made these more difficult treat, by limiting the effective drug options available. This systematic review meta-analysis aim provide an updated summary of prevalence AMR over past 5 years. A search was performed across three major electronic databases—PubMed, ScienceDirect, Web Science—yielding 40 eligible studies published between 2018 2023. Using random-effects model, our estimated that overall Asia Africa years 22.9% (95% CI [14.4–31.4]). for multidrug-resistant (MDR) extensively drug-resistant (XDR) were found 46.0% [37.1–55.0]) 19.6% [4.3–34.9]), respectively. Furthermore, extended-spectrum β-lactamase- metallo-β-lactamase-producing 33.4% [23.6–43.2]) 16.0% [9.8–22.3]), Notably, resistance β-lactams used treating pseudomonal alarmingly high, with 84.4% 100.0% cephalosporins, 40% isolates showed penicillins. Our analysis identified lowest last-resort antimicrobials, 0.3% [0.0–1.3]) polymyxin B 5.8% [1.5–10.2]) colistin/polymyxin E. low polymyxins suggest antibiotics remain against MDR . However, findings also highlight critical public health threat posed , concerning β-lactam antibiotics. underscores need carefully planned intervention strategies, development new address growing challenge resistance. Developing robust antibiotic treatment protocols is essential better management control globally. Therefore, continued research international collaboration vital tackle this escalating challenge. study protocol registered International Prospective Register Systematic Reviews (PROSPERO), under registration number CRD42023412839.

Language: Английский

Citations

1

Activity of Antiseptics Against Pseudomonas aeruginosa and Its Adaptation Potential DOI Creative Commons
Tomasz M. Karpiński,

Marzena Korbecka-Paczkowska,

Mark Stasiewicz

et al.

Antibiotics, Journal Year: 2025, Volume and Issue: 14(1), P. 30 - 30

Published: Jan. 3, 2025

Background/Objectives: Pseudomonas aeruginosa rapidly acquires antibiotic resistance and demonstrates increasing tolerance to antiseptics. This study evaluated the activity of eight antiseptics against P. aeruginosa, assessed its ability develop adaptation these antiseptics, and, for first time, determined Karpinski Adaptation Index (KAI) this bacterium. Methods: The minimal inhibitory concentration (MIC), susceptibility antibiotics, bactericidal time according EN 1040:2005, potential, KAI strains were evaluated. Results: most effective based on MIC activity, octenidine dihydrochloride (OCT; mean 11.3 ± 4.5 µg/mL), polyhexamethylene biguanide (PHMB; 22.6 8.0 chlorhexidine digluconate (CHX; 26.6 14.4 µg/mL). Sodium hypochlorite (NaOCl) ethacridine lactate (ET) showed moderate while boric acid (BA), povidone-iodine (PVI), potassium permanganate (KMnO4) exhibited weakest activity. values NaOCl (95 15.4 µg/mL) KMnO4 (>10 mg/mL) close or exceeded clinical concentrations used in commercial products. OCT, CHX, PVI fastest effect within 1 min. Bactericidal times up 15 min PHMB, 60 ET, more than BA, NaOCl, KMnO4. lowest values, indicating a low risk, observed OCT (0.12), PHMB (0.19), BA (0.19). Moderate risk was noted (0.21), CHX (0.29), ET (0.47). highest signifying very high found (1.0) (≥1.0). Conclusions: Antiseptics like partially can be critical quick antibacterial action infected wounds, agents such as might reserved cases where prolonged contact are possible. Given rapid currently use, reconsideration their effectiveness treating skin mucous membrane infections is recommended.

Language: Английский

Citations

1

Measuring water pollution effects on antimicrobial resistance through explainable artificial intelligence DOI Creative Commons
A. Monaco,

Mario Caruso,

Loredana Bellantuono

et al.

Environmental Pollution, Journal Year: 2025, Volume and Issue: unknown, P. 125620 - 125620

Published: Jan. 1, 2025

Language: Английский

Citations

1

Complete genome sequence of Pseudomonas aeruginosa YK01, a sequence type 16 isolated from a patient with keratitis DOI Creative Commons
Shuo Jiang,

Mengmin Ye,

Ke Liu

et al.

BMC Genomic Data, Journal Year: 2025, Volume and Issue: 26(1)

Published: Jan. 22, 2025

Pseudomonas aeruginosa, a Gram-negative opportunistic pathogen, is frequently associated with multidrug resistance and global epidemic outbreaks, contributing significantly to morbidity mortality in hospitalized patients. However, P. aeruginosa belonging the sequence type (ST) 16 was rarely reported. Here, this report presents complete genome of YK01, ST16 isolate from patient keratitis. The reference YK01 expected provide valuable data for investigating its genomic population, enhancing understanding genetic basis species complex. A 6.3 Mb obtained by combining Illumina 150-bp short reads Nanopore long reads. assembly fully chromosomal size 6,183,266 bp, presenting GC content 66.7%, plasmid 46,067 59.0%. Predicted features include 5,709 CDS, 12 rRNAs, 63 tRNAs, 4 ncRNAs, 5,788 genes. To our knowledge, represents first ST16, providing crucial information further comparative analysis.

Language: Английский

Citations

1

Impact of Antimicrobial Resistance of Pseudomonas aeruginosa in Urine of Small Companion Animals in Global Context: Comprehensive Analysis DOI Creative Commons
Ana Pereira, Telma de Sousa, Catarina Silva

et al.

Veterinary Sciences, Journal Year: 2025, Volume and Issue: 12(2), P. 157 - 157

Published: Feb. 11, 2025

The isolation of multidrug-resistant (MDR) bacteria from the urinary tracts pets is increasingly common, particularly in animals with concurrent health conditions. Pseudomonas aeruginosa (PA) one most significant antimicrobial-resistant affecting cats and dogs within European Union (EU). This study aims to review prevalence antimicrobial resistance patterns PA isolated urine samples small globally. pathogen known for its opportunistic infections a concern veterinary medicine due inherent multiple antibiotics ability acquire additional mechanisms. seeks enhance educational initiatives regarding management emerging MDR bacteria.

Language: Английский

Citations

1

Leveraging bacteria-inspired nanomaterials for targeted controlling biofilm and virulence properties of Pseudomonas aeruginosa DOI
Palanivel Sathishkumar, Fazlurrahman Khan

Microbial Pathogenesis, Journal Year: 2024, Volume and Issue: 197, P. 107103 - 107103

Published: Nov. 5, 2024

Language: Английский

Citations

4

Exploring Bacteriophage Applications in Medicine and Beyond DOI Open Access
Ahmed Elfadadny, Rokaia F. Ragab,

Manar A. Abou Shehata

et al.

Deleted Journal, Journal Year: 2024, Volume and Issue: 69(3), P. 167 - 179

Published: July 8, 2024

Bacteriophages, or phages, are microscopic viruses that specifically infect and replicate within bacterial hosts. Their unique ability to target control populations makes them valuable tools with applications ranging from human medicine agriculture environmental management biotechnology. In this comprehensive review, we explore the diverse promising medical non-medical of bacteriophages, highlighting their pivotal role across various niches. From safeguarding food production through pathogen innovative utilization in wastewater treatment, bacteriophages prove be versatile agents. To achieve phages on a larger scale, it is necessary make legal framework more suitable flexible, create special approval programs (e.g., for novel antimicrobial drugs), promote targeted research development activities phages. Additionally, intensive exchange between academia, industry, regulatory authorities, stakeholders health system should pursued.

Language: Английский

Citations

3

Exploring Antibacterial Properties of Marine Sponge-Derived Natural Compounds: A Systematic Review DOI Creative Commons
Cintia Cristina Santi Martignago, Camila de Souza Barbosa,

Homero Garcia Motta

et al.

Marine Drugs, Journal Year: 2025, Volume and Issue: 23(1), P. 43 - 43

Published: Jan. 16, 2025

The rise in multidrug-resistant (MDR) bacteria has prompted extensive research into antibacterial compounds, as these resistant strains compromise current treatments. This resistance leads to prolonged hospitalization, increased mortality rates, and higher healthcare costs. To address this challenge, the pharmaceutical industry is increasingly exploring natural products, particularly those of marine origin, promising candidates for antimicrobial drugs. Marine sponges, particular, are interest because their production secondary metabolites (SM), which serve chemical defenses against predators pathogens. These exhibit a wide range therapeutic properties, including activity. systematic review examines recent advancements identifying new sponge-derived compounds with activity, specifically targeting Pseudomonas aeruginosa, prevalent Gram-negative pathogen highest incidence rates clinical settings. selection criteria focused on reported Minimum Inhibitory Concentration (MIC) values. identified SM include alkaloids, sesterterpenoids, nitrogenous diterpene, bromotyrosine-derived derivatives. structural features active selected may provide foundational framework developing new, highly bioactive agents.

Language: Английский

Citations

0

Phage treatment of multidrug-resistant bacterial infections in humans, animals, and plants: The current status and future prospects DOI Creative Commons
Omor Faruk, Zilhas Ahmed Jewel,

Sanjoy Bairagi

et al.

Infectious Medicine, Journal Year: 2025, Volume and Issue: 4(1), P. 100168 - 100168

Published: Feb. 6, 2025

Phages, including the viruses that lyse bacterial pathogens, offer unique therapeutic advantages, their capacity to antibiotic-resistant bacteria and disrupt biofilms without harming host microbiota. The lack of new effective antibiotics growing limitations existing have refocused attention on phage therapy as an option in complex clinical cases such burn wounds, cystic fibrosis, pneumonia. This review describes preclinical studies which has been both human veterinary medicine, agricultural context. In addition, critical challenges, narrow range bacteriophages, possibility resistance, regulatory constraints widespread use therapy, are addressed. Future directions include optimizing through strategies ranging from cocktails broadening genetic modification, using phages vaccines or biocontrol agents. future, if can be efficiently delivered, maintained a stable state, phage-antibiotic synergy achieved, will much needed treatment options. However, successful implementation within current standards practice also require considerable development infrastructure greater public acceptance. closing, this highlights promise backup substitute for antibiotics. It proposes role significant adjunct to, even replacement for, treating multidrug-resistant infections.

Language: Английский

Citations

0

Comparison between the effect of gentamicin and purified Lactobacillus salivarius exopolysaccharides on the biofilm formation and Pseudomonas aeruginosa Rh1I gene expression DOI

H. Ayaat,

Ibtesam Ghadban Auda,

Likaa Hamied Mahdi

et al.

Gene Reports, Journal Year: 2025, Volume and Issue: unknown, P. 102164 - 102164

Published: Feb. 1, 2025

Language: Английский

Citations

0